Application 202523
- Type
- ANDA
- Sponsor
- MYLAN PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEVIRAPINE | NEVIRAPINE | TABLET;ORAL | 200MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-4050 | Nevirapine | nevirapine | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 53808-0680 | Nevirapine | nevirapine | State of Florida DOH Central Pharmacy | ANDA | Current |